E. Pegoraro et al., FAMILIAL SKEWED-X INACTIVATION - A MOLECULAR TRAIT ASSOCIATED WITH HIGH SPONTANEOUS-ABORTION RATE MAPS TO XQ28, American journal of human genetics, 61(1), 1997, pp. 160-170
We report a family ascertained for molecular diagnosis of muscular dys
trophy in a young girl, in which preferential activation (greater than
or equal to 95% of cells) of the paternal X chromosome was seen in bo
th the proband and her mother. To determine the molecular basis for sk
ewed X inactivation, we studied X-inactivation patterns in peripheral
blood and/or oral mucosal cells from 50 members of this family and fro
m a cohort of normal females. We found excellent concordance between X
-inactivation patterns in blood and oral mucosal cell nuclei in all fe
males. Of the 50 female pedigree members studied, 16 showed preferenti
al use (greater than or equal to 95% cells) of the paternal X chromoso
me; none of 62 randomly selected females showed similarly skewed X ina
ctivation (P <.0003). The trait for skewed X inactivation was maternal
ly inherited in this family. A linkage study using the molecular trait
of skewed X inactivation as the scored phenotype localized this trait
to Xq28 (DXS1108; maximum LOD score [Z(max)] = 4.34, recombination fr
action [theta] = 0). Both genotyping of additional markers and FISH of
a YAC probe in Xq28 showed a deletion spanning from intron 22 of the
factor VIII gene to DXS115-3. This deletion completely cosegregated wi
th the trait (Z(max) = 6.92, theta = 0). Comparison of clinical findin
gs between affected and unaffected females in the 50-member pedigree s
howed a statistically significant increase in spontaneous-abortion rat
e in the females carrying the trait (P <.02). To our knowledge, this i
s the first gene-mapping study of abnormalities of X-inactivation patt
erns and is the first association of a specific locus for recurrent sp
ontaneous abortion in a cytogenetically normal family. The involvement
of this locus in cell lethality, cell-growth disadvantage, developmen
tal abnormalities, or the X-inactivation process is discussed.